fasting glucose

fasting glucose

Fasting blood sugar, fasting plasma glucose Endocrinology Glucose obtained from a Pt who has had nothing–except water by mouth for 8+ hrs; FG is used in evaluating Pts for possible DM Ref range 65-115 mg/dL non-diabetic; 110-140 mg/dL, possible GTT warranted; > 140 DM. See Diabetes mellitus, Glucose tolerance test.
References in periodicals archive ?
Anthropometric parameters including age, body mass index (BMI), waist circumference, waist-hip ratio (WHR), diastolic and systolic blood pressure, lipid profile and fasting glucose, serum resistin and insulin of three hundred over weight, obese males and females, 17 to 30 years and 100 comparable control subjects were included.
Previous studies have shown that risk factors for type 2 diabetes, including obesity and elevated fasting glucose, may be present up to 10 years before disease onset.
That's because the last marker to elevate in patients with poor glycemic control is often fasting glucose.
Pre-diabetes is the state of impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) (fasting blood glucose = 100-125 mg/dl) either alone or in combination.
1c] levels at any given concentration of fasting glucose than do those who don't have sickle cell trait, according to a report published online in JAMA.
1c], and fasting glucose, (b) the hematological indices, hemoglobin, mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), and erythrocyte count, and (c) the renal and hepatic indices, creatinine, estimated glomerular filtration rate (eGFR), aspartate aminotransferase (AST), alanine aminotransferase (ALT), [gamma]-glutamyltransferase (GGT), bilirubin, and albumin was obtained between 2008 and 2013 inclusive (only the first such profile of each patient during this period was considered).
Only data from individuals with fasting glucose levels in the non-diabetic range (<125 mg/dl) were included.
This study aimed to assess the relationship between arterial stiffness and impaired fasting glucose (IFG) levels.
The AHA recently defined ideal target levels for seven modifiable cardiovascular (CV) risk factors: smoking status, body mass index, physical activity level, diet, blood pressure, total cholesterol level, and fasting glucose level.
Objective: To assess the effects of hepatitis C virus infection in the first 5 years on fasting glucose, fasting insulin and peripheral insulin resistance.
The earlier Phase 1b trial of TTP273 indicated robust effects on postprandial and fasting glucose.